Sanara MedTech (SMTI|$306.0M) - 2025 Q1 Earnings Analysis

Описание: #SMTI Sanara MedTech 2025 Q1 Earnings: Sanara MedTech reported a 26% increase in revenue for Q1 2025, despite missing EPS expectations.

Revenue: $23.4 million

Adj. EPS: -$0.41 vs. forecast -$0.31 (1 analyst)

Net Loss: $3.5 million

Gross Margin: 92%

"The commercial team for our Sanara Surgical segment delivered a strong start to 2025, with net revenue growth in the first quarter of 26% year-over-year, which was consistent with our expectations," stated Ron Nixon, Sanara’s Executive Chairman and CEO.

If you enjoyed this video, please like, subscribe, and hit the notification bell to stay updated with our latest stock analysis and market insights. Leave a comment below with your thoughts on the video, and any other stocks you'd like us to cover.

Check out our latest videos on more earnings:

#KMDA Kamada 2025 Q1 Earnings:    • Kamada (KMDA|$392.2M) - 2025 Q1 Earnings A...  

#BITF Bitfarms 2025 Q1 Earnings:    • Bitfarms (BITF|$603.5M) - 2025 Q1 Earnings...  

#SDHC Smith Douglas Homes 2025 Q1 Earnings:    • Smith Douglas Homes (SDHC|$1.0B) - 2025 Q1...  

#MRP Millrose Properties 2025 Q1 Earnings:    • Millrose Properties (MRP|$4.4B) - 2025 Q1 ...  

#N/A Scholar Rock 2025 Q1 Earnings:    • Scholar Rock (N/A|$3.1B) - 2025 Q1 Earning...